Clinical Trial: Colchicine Effect on Amyotrophic Lateral Sclerosis Patients

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07813858) titled 'Colchicine Effect on Amyotrophic Lateral Sclerosis Patients' on Sept. 02.

Brief Summary: The goal of this clinical trial is to evaluate whether low-dose colchicine can slow disease progression in patients with amyotrophic lateral sclerosis (ALS), a progressive and fatal neurodegenerative disorder affecting motor neurons.

The study is designed to answer whether patients receiving colchicine show a slower decline in functional status, as measured by the ALS Functional Rating Scale-Revised (ALSFRS-R), over a 30-week double-blind treatment period compared to patients receiving placebo. Additional questions include whether colchicine h...